A common variant in PIK3CG gene associated with the prognosis of heart failure

Dong Hu1,2, Lei Xiao3, Shiyang Li4

  • 1Division of Cardiology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Insights

Common variants in the Phosphoinositide 3-kinase γ (PI3Kγ) gene (PIK3CG) impact heart failure (HF) prognosis. A specific PIK3CG variant affects gene expression and may offer a therapeutic target for HF treatment.

Area of Science:

  • Cardiovascular Biology
  • Genetics
  • Molecular Medicine

Background:

  • Phosphoinositide 3-kinase γ (PI3Kγ) plays a role in myocardial remodeling and heart failure (HF).
  • PI3Kγ exhibits both kinase-dependent and kinase-independent activities, influenced by G-protein-coupled receptors.
  • Previous research indicates PI3Kγ involvement in conditions like transientאַקטיביטי (TAC) and ischemia/reperfusion (I/R) injury.

Purpose of the Study:

  • To investigate the association between common variants in the PI3Kγ gene (PIK3CG) and the prognosis of heart failure (HF).
  • To explore the functional mechanisms by which identified genetic variants influence PIK3CG expression and cellular response.
  • To assess the potential of PIK3CG as a therapeutic target for HF.

Main Methods:

  • Re-sequencing and genotyping of the PIK3CG gene in a Chinese Han population.
  • Two-stage population study design to validate genetic associations.
  • Functional assays including analysis of microRNA binding (has-miR-133a-3p), mRNA and protein expression, and cellular apoptosis under hypoxia/reoxygenation (H/R) conditions.

Main Results:

  • A common variant (rs10215499) in the 3'UTR of PIK3CG was significantly associated with HF prognosis in both study cohorts.
  • The rs10215499-A allele suppressed PIK3CG translation by enhancing has-miR-133a-3p binding, leading to lower mRNA and protein levels compared to the GG genotype.
  • Overexpression of PIK3CG protected against H/R-induced apoptosis in AC16 cells, while PIK3CG silencing exacerbated it.

Conclusions:

  • The common variant rs10215499 in the PIK3CG 3'-UTR may influence HF prognosis by modulating miR-133a-3p binding and subsequent PIK3CG expression.
  • PIK3CG demonstrates a protective role against hypoxia/reoxygenation-induced apoptosis in cardiomyocytes.
  • PIK3CG represents a potential therapeutic target for future heart failure treatments.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.2K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.4K